# Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

> **NCT00793052** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Trismus
- Edema
- Pain

## Interventions

- **DRUG:** Etodalac, Etoricoxib and Dexamethasone

## Key facts

- **NCT ID:** NCT00793052
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2008-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00793052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00793052, "Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00793052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*